Sandlie; Inger
Patent Applications and Registrations
Patent applications and USPTO patent grants for Sandlie; Inger.The latest application filed is for "antigen binding proteins which bind to the pmhc hla-dq2.5:dq2.5 presenting a gliadin peptide".
Company Profile
11.24.43
- Sandlie; Inger - Oslo NO
Patent Activity
| Patent | Date |
|---|---|
| Engineered immunoglobulins with altered FcRn binding Grant 11,319,383 - Andersen , et al. May 3, 2 | 2022-05-03 |
| Vector construct Grant 11,306,318 - Loset , et al. April 19, 2 | 2022-04-19 |
| ANTIGEN BINDING PROTEINS WHICH BIND TO THE pMHC HLA-DQ2.5:DQ2.5 PRESENTING A GLIADIN PEPTIDE App 20210147552 - LOSET; Geir ge ; et al. | 2021-05-20 |
| Albumin Variants App 20200385442 - Sleep; Darrell ; et al. | 2020-12-10 |
| Albumin variants and uses thereof Grant 10,781,245 - Andersen , et al. Sept | 2020-09-22 |
| Albumin variants Grant 10,696,732 - Sleep , et al. June 30, 2 | 2020-06-30 |
| Multivalent phage display systems and methods Grant 10,640,761 - Loset , et al. | 2020-05-05 |
| Albumin Variants App 20200102368 - Andersen; Jan Terje ; et al. | 2020-04-02 |
| Blockade Of Alphafetoprotein (afp) Interactions With Beta2-microglobulin Associated Molecules App 20190201496 - BLUMBERG; Richard S. ; et al. | 2019-07-04 |
| Albumin Variants And Uses Thereof App 20190135895 - Andersen; Jan Terje ; et al. | 2019-05-09 |
| Pharmacokinetic Animal Model App 20190113519 - Cameron; Jason ; et al. | 2019-04-18 |
| Albumin derivatives and variants Grant 10,233,228 - Plumridge , et al. | 2019-03-19 |
| Engineered Immunoglobulins With Altered Fcrn Binding App 20190077883 - ANDERSEN; Jan Terje ; et al. | 2019-03-14 |
| Albumin variants and uses thereof Grant 10,208,102 - Andersen , et al. Feb | 2019-02-19 |
| Albumin Variants App 20180265570 - Sleep; Darrell ; et al. | 2018-09-20 |
| Albumin Variants App 20180222963 - Sleep; Darrell ; et al. | 2018-08-09 |
| Albumin Variants App 20180162925 - Sleep; Darrell ; et al. | 2018-06-14 |
| Albumin Variants App 20180105578 - Sleep; Darrell ; et al. | 2018-04-19 |
| Albumin Variants App 20180105576 - Sleep; Darrell ; et al. | 2018-04-19 |
| Albumin Variants App 20180105577 - Sleep; Darrell ; et al. | 2018-04-19 |
| Albumin Variants App 20180072792 - Sleep; Darrell ; et al. | 2018-03-15 |
| Modified Antibody App 20180030155 - BOGEN; Bjarne ; et al. | 2018-02-01 |
| Modified antibody Grant 9,796,787 - Bogen , et al. October 24, 2 | 2017-10-24 |
| Multivalent Phage Display Systems And Methods App 20170211060 - Loset; Geir Age ; et al. | 2017-07-27 |
| Anti-cd14 Antibodies And Uses Thereof App 20170107294 - Espevik; Terje ; et al. | 2017-04-20 |
| Albumin Variants And Uses Thereof App 20160280763 - Andersen; Jan Terje ; et al. | 2016-09-29 |
| Albumin Variants App 20160075759 - Sleep; Darrell ; et al. | 2016-03-17 |
| Albumin Variants App 20160075761 - Sleep; Darrell ; et al. | 2016-03-17 |
| Albumin Variants App 20160075757 - Sleep; Darrell ; et al. | 2016-03-17 |
| Albumin Variants App 20160075762 - Sleep; Darrell ; et al. | 2016-03-17 |
| Albumin Variants App 20160075760 - Sleep; Darrell ; et al. | 2016-03-17 |
| Albumin Variants App 20160075758 - Sleep; Darrell ; et al. | 2016-03-17 |
| Albumin Variants App 20160075756 - Sleep; Darrell ; et al. | 2016-03-17 |
| Albumin Variants App 20160075763 - Sleep; Darrell ; et al. | 2016-03-17 |
| Modified Antibody App 20160039946 - BOGEN; Bjarne ; et al. | 2016-02-11 |
| Pharmacokinetic Animal Model App 20160033523 - Cameron; Jason ; et al. | 2016-02-04 |
| Albumin Variants App 20160009787 - Sleep; Darrell ; et al. | 2016-01-14 |
| Modified antibody Grant 9,169,322 - Bogen , et al. October 27, 2 | 2015-10-27 |
| Disulphide bond-stabilized functional soluble MHC class II heterodimers Grant 9,056,920 - Loset , et al. June 16, 2 | 2015-06-16 |
| Modified antibody Grant 8,932,603 - Bogen , et al. January 13, 2 | 2015-01-13 |
| Disulphide Bond-stabilized Functional Soluble Mhc Class Ii Heterodimers App 20140349315 - Loset; Geir Age ; et al. | 2014-11-27 |
| Albumin Variants App 20140315816 - Andersen; Jan Terje ; et al. | 2014-10-23 |
| Disulphide bond-stabilized functional soluble MHC class II heterodimers Grant 8,828,379 - Loset , et al. September 9, 2 | 2014-09-09 |
| Albumin variants Grant 8,822,417 - Andersen , et al. September 2, 2 | 2014-09-02 |
| Albumin Variants App 20140234311 - Sleep; Darrell ; et al. | 2014-08-21 |
| Albumin variants Grant 8,748,380 - Plumridge , et al. June 10, 2 | 2014-06-10 |
| Albumin Variants App 20130225496 - Plumridge; Andrew ; et al. | 2013-08-29 |
| Albumin Derivatives and Variants App 20130028930 - Plumridge; Andrew ; et al. | 2013-01-31 |
| Albumin Variants App 20120322739 - Andersen; Jan Terje ; et al. | 2012-12-20 |
| Multivalent Phage Display Systems And Methods App 20120231525 - Loset; Geir Age ; et al. | 2012-09-13 |
| Albumin Variants App 20120220530 - Plumridge; Andrew ; et al. | 2012-08-30 |
| Modified Antibody App 20120171242 - BOGEN; Bjarne ; et al. | 2012-07-05 |
| Modified antibody App 20040253238 - Bogen, Bjarne ; et al. | 2004-12-16 |
| Anti-cd3 single-chain antibodies having human cmu3 and cmu4 domains App 20040175786 - Choi, Ingrid ; et al. | 2004-09-09 |
| Modified immunoglobulin molecule incorporating an antigen in a non-CDR loop region Grant 6,294,654 - Bogen , et al. September 25, 2 | 2001-09-25 |
| IgG3 antibodies with shortened hinge region and a complement activation test Grant 5,348,876 - Michaelsen , et al. September 20, 1 | 1994-09-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 